CAUTI

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

Retrieved on: 
화요일, 5월 14, 2024
Defense, Health, Medical Devices, Health Technology, Managed Care, Biotechnology, Veterans, SAW, Hospital, Risk, Cardiac catheterization, Sale, Iraq War, CAUTI, CB, Veterans' affairs, Tetraplegia, Incidence, Pain, Veteran, Infection, Medical imaging

NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with CB Medical, LLC (“CB Medical”) for the sale and distribution of the Company’s UroShield.

Key Points: 
  • NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with CB Medical, LLC (“CB Medical”) for the sale and distribution of the Company’s UroShield.
  • CB Medical is a U.S. Department of Veteran Affairs (“VA”) certified and Service-Disabled Veteran-Owned Small Business (“SDVOSB”) with two decades of experience serving veterans.
  • Under the terms of the multi-year agreement, CB Medical has the right to sell and distribute UroShield to its customers throughout the VA system in the United States.
  • Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., commented, "This new agreement provides us with another distribution channel for UroShield within the VA system of providers.

Press Ganey Announces Integration of Nursing Quality Data from Epic

Retrieved on: 
월요일, 4월 8, 2024
Practice Management, Nursing, General Health, Health, Consulting, Hospitals, Professional Services, Other Health, Epic Systems, Patient, Organization, Documentation, Fungal infection, NSI, Press Ganey Associates, MSN, Safety, CLABSI, CAUTI

AONL CONFERENCE– Press Ganey , the leading provider of experience measurement, data analytics and insights to health systems and health plans, today announced a collaboration to integrate nurse-sensitive indicators (NSI) and outcomes from Epic into Press Ganey’s National Database of Nursing Quality Indicators (NDNQI).

Key Points: 
  • AONL CONFERENCE– Press Ganey , the leading provider of experience measurement, data analytics and insights to health systems and health plans, today announced a collaboration to integrate nurse-sensitive indicators (NSI) and outcomes from Epic into Press Ganey’s National Database of Nursing Quality Indicators (NDNQI).
  • The integration and automated reporting will save nursing and quality leaders time, support nursing excellence and accelerate the work to improve patient care.
  • "Our expanded collaboration with Epic to integrate reporting of nursing sensitive indicators is a pivotal step towards using real-time data to improve the experience and quality of care," said Darren Dworkin, President and Chief Operating Officer for Press Ganey.
  • Through the “PX Connect Suite”, joint Press Ganey and Epic clients can surface patient experience insights to frontline staff for patient care and service recovery.

Healthcare Safety Outcomes Are Improving but Patient and Workforce Experience Paints Mixed Picture, Press Ganey Report Finds

Retrieved on: 
화요일, 4월 2, 2024
Professional Services, Nursing, Health, Hospitals, Managed Care, General Health, Consulting, Culture, Organization, Government, VAE, Safety, Press Ganey Associates, Patient, PSO, Hospital, Health care, Transformation, Fear, Yoy, Catheter-associated urinary tract infection, Human, CLABSI, Patient safety organization, Data, CAUTI, Violence

Press Ganey , the leader in helping healthcare providers and health plans transform the Human Experience, today published its new report, “Safety in Healthcare 2024.” This first-of-kind report analyzes Press Ganey's integrated dataset of safety outcomes, event reporting, workforce culture, and patient perceptions representing 12 million patient encounters, 1 million healthcare employees, as well as over 550,000 reported safety events in 2023.

Key Points: 
  • Press Ganey , the leader in helping healthcare providers and health plans transform the Human Experience, today published its new report, “Safety in Healthcare 2024.” This first-of-kind report analyzes Press Ganey's integrated dataset of safety outcomes, event reporting, workforce culture, and patient perceptions representing 12 million patient encounters, 1 million healthcare employees, as well as over 550,000 reported safety events in 2023.
  • While safety outcomes are on a promising trajectory and patient perceptions in outpatient settings are rising, nearly half of all staff and almost one-third of inpatients report low perceptions of safety.
  • “Healthcare organizations that do best on safety embrace a holistic approach, with safety as a core value grounded in both patient and employee experiences.
  • For more information about Press Ganey and the “Safety in healthcare 2024” report, visit https://info.pressganey.com/e-books-research/safety-2024

TRAQC, ClearVision, and UriMetrics Awarded Top Three Places at 2024 SPIE Startup Challenge

Retrieved on: 
수요일, 1월 31, 2024
Health, Technology, Photography, Health Technology, Other Technology, Optical, Hardware, Multimedia, CAUTI, SPIE, Terahertz, Incidence, Radiation, Medical imaging

Yesterday, at a ceremony during SPIE Photonics West , TRAQC was announced the winner of the $10,000 top prize at the 14th annual SPIE Startup Challenge .

Key Points: 
  • Yesterday, at a ceremony during SPIE Photonics West , TRAQC was announced the winner of the $10,000 top prize at the 14th annual SPIE Startup Challenge .
  • Their real-time inspection solution for the printed electronics industry utilizes THz radiation and metamaterial technology to ensure quality while reducing waste.
  • View the full release here: https://www.businesswire.com/news/home/20240131233858/en/
    Jenoptik’s Ralf Kuschnereit, TRAQC's Benjamin Dringoli, and 2024 SPIE President Jennifer Barton.
  • All cash prizes are provided by SPIE Startup Challenge Founding Partner Jenoptik.

NanoVibronix Featured in Your Bladder Health Magazine

Retrieved on: 
수요일, 12월 6, 2023
Biotechnology, General Health, Medical Devices, Health, Health Technology, Urinary bladder, NHS, Urinary tract infection, Patient, Multimedia, Jimmy Cauty, SAW, CAUTI, Pharmaceutical industry

NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield is featured in Issue 103 of Your Bladder Health Magazine in an article titled ‘UroShield Prevention is better than cure.’ The article highlights the effectiveness of using UroShield in the prevention of catheter associated urinary tract infections (CAUTIs).

Key Points: 
  • NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that its UroShield is featured in Issue 103 of Your Bladder Health Magazine in an article titled ‘UroShield Prevention is better than cure.’ The article highlights the effectiveness of using UroShield in the prevention of catheter associated urinary tract infections (CAUTIs).
  • The article also includes testimonials that detail the positive impact that UroShield has had on the lives of patients.
  • View the full release here: https://www.businesswire.com/news/home/20231206453100/en/
    Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, “This article reinforces our efforts to raise market and clinician awareness, a key driver to accelerating adoption and increasing sales.
  • Thankfully UroShield addresses and solves all these serious concerns and has some additional benefits to users in reducing pain associated with catheter use, and a reduction in bladder spasms which some people suffer from.’

New Hospital Safety Grades from The Leapfrog Group Find Improved Infection Rates Following Major Spike During COVID-19 Pandemic

Retrieved on: 
월요일, 11월 6, 2023
Patient, Staphylococcus aureus, Patient safety organization, Infection, Houston, CLABSI, COVID-19, Medicine, MRSA, Binder, Hospital, Accident, Catheter-associated urinary tract infection, Approximation error, Movement, The Post-Pandemic World Order, Communication, Letter, Dentistry, Nursing, CAUTI

WASHINGTON, Nov. 6, 2023 /PRNewswire/ -- The Leapfrog Group, an independent national nonprofit driving a movement for patient safety, today released its fall 2023 Hospital Safety Grades, assigning a letter grade to nearly 3,000 general hospitals on how well they prevent medical errors, accidents and infections. The latest grades show hospitals reducing health care-acquired infections (HAIs) post-pandemic after significant increases in infection rates during the COVID-19 pandemic. This cycle, nearly 30% of hospitals earned an "A," 24% earned a "B," 39% earned a "C," 7% earned a "D" and less than 1% earned an "F."

Key Points: 
  • The latest grades show hospitals reducing health care-acquired infections (HAIs) post-pandemic after significant increases in infection rates during the COVID-19 pandemic.
  • The Leapfrog Hospital Safety Grade also includes five patient experience measures that evidence suggests are closely associated with patient safety issues.
  • The Leapfrog Hospital Safety Grade is the only hospital ratings program based exclusively on hospital prevention of medical errors and harms to patients.
  • For more information about the Hospital Safety Grades, including details on individual hospital grades and state rankings, please visit HospitalSafetyGrade.org .

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

Retrieved on: 
수요일, 9월 6, 2023
Medical Devices, Health, Health Technology, Clinical Trials, Research, Science, Infection, SAW, International Continence Society, ICS, Patient, Urology, Nursing, Bacteria, CAUTI, Catheter-associated urinary tract infection, Conference, Medical imaging

The ICS annual conference brings together international experts in the research and treatment of bladder problems, pelvic floor disorders and Lower Urinary Tract Symptoms.

Key Points: 
  • The ICS annual conference brings together international experts in the research and treatment of bladder problems, pelvic floor disorders and Lower Urinary Tract Symptoms.
  • All ICS attendees will have the opportunity to learn about the UroShield® device and explore how the device can be introduced to their patients across the globe.
  • Through this independent study, researchers witnessed positive outcomes from the use of UroShield both in the lab and with patients.
  • It is designed to prevent biofilm formation, decrease bacteriuria/UTI, reduce catheter pain and discomfort and increase antibiotic efficacy.

NanoVibronix Cites Positive Results from Independent Testing of UroShield

Retrieved on: 
수요일, 8월 30, 2023
Medical Devices, Health, Health Technology, Clinical Trials, Research, Science, Proteus mirabilis, University, Use, ScienceDirect, Urine, SAW, Infection, Patient, Risk, United Kingdom, CAUTI, Bacteria, Catheter-associated urinary tract infection, Medical imaging, Medical device, Proteus

NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today cited positive reported outcomes from a study of UroShield® that was conducted at the University of Southampton in the United Kingdom.

Key Points: 
  • NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today cited positive reported outcomes from a study of UroShield® that was conducted at the University of Southampton in the United Kingdom.
  • We are pleased to learn that through an independent study, researchers witnessed positive outcomes from the use of UroShield both in the lab and with patients.
  • Quantitative data from the research indicated a positive effect of UroShield on catheter-associated urinary tract infections (CAUTI) and catheter blockage with approximately one-third of patients in the study citing a reduction in the frequency of catheter blockages and the need for unscheduled catheter challenges.
  • It is designed to prevent biofilm formation, decrease bacteriuria/UTI, reduce catheter pain and discomfort and increase antibiotic efficacy.

Potrero Medical announces Sandra Morgan to join Advisory Board

Retrieved on: 
수요일, 5월 31, 2023
Hospice and palliative medicine, AKI, Patient, Standard of care, Risk, Morgan, Growth, CAUTI, Health, HCA Healthcare

HAYWARD, Calif., May 31, 2023 /PRNewswire/ -- Potrero Medical, innovator of the Accuryn Monitoring System, announced today that Sandra Morgan has joined their advisory board effective immediately.

Key Points: 
  • HAYWARD, Calif., May 31, 2023 /PRNewswire/ -- Potrero Medical, innovator of the Accuryn Monitoring System, announced today that Sandra Morgan has joined their advisory board effective immediately.
  • Morgan served as an executive at HCA Healthcare, one of the nation's leading providers of healthcare services, for 13 years, before retiring on June 1, 2021.
  • "We are excited to welcome Sandra to our advisory board.
  • Morgan added, "I am thrilled to join Potrero Medical's advisory board.

Intellego Technologies Partners With HAI Solutions for a Novel Application of Ultraviolet Photochromic Ink for an Intravenous Port Disinfection Technology to Mitigate Risk of Contamination

Retrieved on: 
월요일, 5월 22, 2023
Biotechnology, Medical Devices, Infectious Diseases, Hospitals, Health, Partnership, Patient safety organization, BSI, Methicillin-resistant Staphylococcus aureus, Hospital, Original equipment manufacturer, COVID-19, CLABSI, MRSA, TM, Multimedia, HOB, Houston, Risk, Blood culture, CAUTI, Fungal infection, Catheter-associated urinary tract infection, Death, Bloodstream infections, Safety, Paint, Pharmaceutical industry

Intellego Technologies and HAI Solutions are proud to announce a strategic partnership that is designed to improve the quality and safety of intravenous (IV) vascular access.

Key Points: 
  • Intellego Technologies and HAI Solutions are proud to announce a strategic partnership that is designed to improve the quality and safety of intravenous (IV) vascular access.
  • The partnership combines Intellego's patented ultraviolet-sensitive ink as an indicator component in HAI Solutions' QIKcap™ technology to offer visible and verifiable IV port protection and provide confidence that the needle-free connector has been disinfected.
  • (Photo: Business Wire)
    The QIKcap Disinfection Device™ is a patented, handheld UV-C tool that is designed to irradiate the surface of an intravenous connector and intravenous access points to prevent microbial ingress.
  • Our partnership with HAI Solutions demonstrates our commitment to life-saving technologies and promoting the safety, efficacy and efficiency of ultraviolet disinfection applications.”
    "We are thrilled to announce our new strategic partnership with Intellego Technologies,” said Nicholas Perrenoud, CEO of HAI Solutions.